October 12, 2009 – The Society of Cardiovascular Computed Tomography (SCCT) announced four new Category 1 CPT codes for cardiac computed tomography will become effective Jan. 1, 2010.

October 12, 2009 – Medtronic Inc. recent received CE mark and began its international launch of the Captivia Delivery System for the Valiant Thoracic Stent Graft, a minimally invasive treatment for aneurysms and other lesions of the thoracic aorta.

October 11, 2009 – GE Healthcare announced the European launch of Discovery NM/CT 670, a hybrid imaging platform designed to improve workflow, dose management, and overall image quality, during the EANM'09 Annual Congress of the European Association of Nuclear Medicine, held Oct. 10-14 in Barcelona, Spain.

October 12, 2009 – Medicare regulatory changes expected to be finalized in November pose a threat to 80 million American patients suffering from heart disease, especially for the nearly one in four over the age of 65 living in rural areas, according to the medical lobby group Guarding Hearts Alliance.

October 9, 2009 – Clarian Cardiovascular has established the Midwest’s only Transradial Center of Excellence in an effort to offer patients a catheterization procedure that significantly reduces recovery time and improves patient outcomes using transradial cardiac catheterization instead of femoral access.

October 9, 2009 – CardioPharma is beginning the final funding phase before submitting an FDA new drug application (NDA) for CardiaPill, the world's first patented triple-combination cardiovascular polypill.

October 9, 2009 – Cook Inc. has filed a lawsuit with the U.S. District Court, Southern District of Indiana, against Endologix Inc., claiming infringement of two critical patents for endovascular stent-grafts used for endovascular repair of aortic aneurysms (EVAR).

October 8, 2009 – The primary results from its groundbreaking PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) clinical trial were released at TCT 2009 in September, which shows promise in identifying and predicting how vulnerable plaque might progress to a cardiac event.

October 8, 2009 – Boston Scientific Corp. this week announced its exclusive sponsorship and first enrollments of the MADIT-RIT clinical trial, which will determine the best device programming strategy to minimize unnecessary therapy in patients with an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) and have no history of cardiac arrest.

October 8, 2009 – In a recent survey of more than 2,000 U.S. physicians conducted by Epocrates Inc., cardiologists and other specialists shared their perspective on the latest patient visit trends and mobile technology use. With patient visits highly affected by the economy, and the use of technology growing among cardiologists, the company said.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now